| 查看: 836 | 回复: 15 | |||
| 当前主题已经存档。 | |||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | |||
yalefield金虫 (文坛精英)
老汉一枚
|
[交流]
FDA QSAR Toxicity Models Now Available
|
||
|
http://www.leadscope.com/fda_qsar_models/ Columbus, Ohio August 26, 2008 – Leadscope announces the availability of the Leadscope FDA QSAR Toxicity Models. Leadscope is making the FDA QSAR Toxicity Models available through a Cooperative Research & Development Agreement with the U.S. Food & Drug Administration (FDA). These models allow scientists to predict the potential toxicity and adverse human clinical effects of pharmaceuticals, cosmetics, food ingredients and other chemicals. The Models are constructed by FDA scientists based on both proprietary and non-proprietary data. Leadscope technology allows delivery of models without disclosing any training sets. The FDA QSAR Toxicity Models will be distributed via annual licenses in Suites containing multiple models relative to specific biological endpoints. The following Suites are now available: Toxicity Endpoints Human Clinical Endpoints ▪ Rodent Carcinogenicity ▪ Cardiological Adverse Effects ▪ Genetic Toxicity ▪ Hepatobiliary Adverse Effects ▪ Reproductive Toxicity ▪ Urinary Tract Adverse Effects ▪ Developmental Toxicity ▪ Neurotoxicity ▪ Misc. Toxicity Endpoints A scientist may enter a single compound or a batch of compounds and receive predictions across multiple endpoints. The FDA QSAR Toxicity Models are a stand-alone product not requiring any other software or training. Loftus Lucas, Leadscope’s CEO, said, “The release of these FDA QSAR Toxicity Models culminates several years of work with the FDA to bring their toxicity data to scientists in an easy to use system. Scientists will get the same prediction from these Models as an FDA Regulator”. The FDA Center for Drug Evaluation and Research (CDER) Informatics and Computational Safety Analysis Staff (ICSAS) and Leadscope are pleased to host a symposium on the use of Leadscope software with FDA databases for QSAR computational toxicology safety analysis at the FDA, other U.S. government agencies and international regulatory bodies. The all-day meeting will be held on September 17, 2008 at the new FDA White Oak Campus in Silver Spring, Maryland. This symposium is free and open to the public. To view the agenda visit www.leadscope.com/fda_symposium.php. Registration is required. Please RSVP by September 12, 2008, at info@leadscope.com. To view the FDA QSAR Model Suites visit Leadscope’s website at www.leadscope.com/fda_qsar_models. For further information or to request on-line demonstration with a Leadscope scientist, contact us at info@leadscope.com. Loftus Lucas Leadscope, Inc. 1393 Dublin Road Columbus, Ohio 43215 Phone: 614-599-2700 Fax: 614-675-3732 info@leadscope.com |
回复此楼» 猜你喜欢
求国际会议网站
已经有1人回复
-
求取一些关于纳米材料和纳米技术相关的英文PPT。
已经有0人回复
-
物理学I论文润色/翻译怎么收费?
已经有172人回复
-
【复旦大学】二维材料方向招收2026年博士研究生1名
已经有0人回复
-
北京纳米能源与系统研究所 王中林院士/曹南颖研究员课题组2026级硕/博/博后招生
已经有10人回复
-
荷兰Utrecht University超快太赫兹光谱王海教授课题招收2026 CSC博士生
已经有22人回复
-
反铁磁体中的磁性切换：两种不同的机制已成功可视化
已经有0人回复
-
26申博推荐：南京航空航天大学国际前沿科学研究院光学方向招收博士生！
已经有0人回复
-
求标准粉末衍射卡号 ICDD 01-076-1802
已经有0人回复
10楼2008-08-29 14:14:59
13楼2008-09-01 21:59:57